Debate on E-cigarette Regulation: UK Parliament vs. WHO

Regulations by 2FIRSTS.ai
Jan.18.2024
Debate on E-cigarette Regulation: UK Parliament vs. WHO
UK Parliament plans to livestream a debate on January 18th regarding e-cigarette regulations, the WHO COP10, and differing stances on e-cigarettes.

The British Parliament is set to hold a live debate on January 18th, focusing on the regulation of e-cigarettes in the country, the upcoming tenth session of the Conference of the Parties (COP10) to the World Health Organization's Framework Convention on Tobacco Control in Panama, and the differing positions of this organization and the UK government regarding e-cigarettes. This debate, initiated by MP Andrew Lewer, aims to examine and challenge the WHO's opposition to e-cigarettes, particularly their policies on banning or overly regulating e-cigarettes, heated tobacco products, and oral nicotine pouches.

 

The World Health Organization (WHO) has long been committed to controlling the use of tobacco and nicotine products, especially e-cigarettes. According to a report on December 14, 2023, the WHO emphasized the need for urgent action to control e-cigarettes in order to protect children and non-smokers, while minimizing the health risks to the public. The WHO pointed out that e-cigarettes contain highly addictive nicotine and are harmful to health.

 

Meanwhile, the stance of the United Kingdom differs significantly from that of the World Health Organization (WHO). The UK government has consistently supported e-cigarettes as a substitute for reducing the harm caused by smoking. According to the UK government's perspective, e-cigarettes can aid smokers in quitting, and their risks are far lower than those associated with traditional tobacco products. A report by the Policy Exchange, a UK policy think tank, demonstrates the enormous impact smoking has on the economy and highlights that reducing smoking rates can not only improve health conditions and alleviate the burden on the National Health Service (NHS) but also stimulate productivity and economic growth.

 

The upcoming debate in the British Parliament is expected to cover various areas, including concerns about the influence of the World Health Organization (WHO) on UK health policies and calls for the UK delegation to uphold its stance on the role of e-cigarettes in smoking cessation on the international stage.

 

The parliamentary debate in the UK has presented a rare opportunity for the public to gain insight into the controversy and intricacies surrounding e-cigarettes within the global tobacco control movement. This debate is expected to offer novel perspectives on the future development of global tobacco control policies.

 

2FIRSTS will be providing full coverage of the entire debate and will provide further updates after its conclusion. Stay tuned for more information.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | BAT Japan Launches virto Bright Peach Click in Japan, Expanding glo Hilo’s Capsule-Based Flavor Portfolio
Product | BAT Japan Launches virto Bright Peach Click in Japan, Expanding glo Hilo’s Capsule-Based Flavor Portfolio
British American Tobacco Japan (BAT Japan) has introduced virto Bright Peach Click, a new heated tobacco stick designed for the glo Hilo system. The product expands the existing virto consumable lineup with a combination of tobacco, menthol and ripe peach flavors, featuring a capsule mechanism that releases additional fruit flavor when activated. The product launched in Japan on July 27, 2026, through glo official online channels, convenience stores and tobacco retailers.
Aug.03
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
A University of Louisville research team published a study in an American Heart Association journal suggesting that synthetic cooling agents used in e-cigarettes, including WS-3 and WS-23, may disrupt cardiac electrical activity and increase arrhythmia risk. In animal experiments, WS-23 tripled premature heartbeats.
Jun.16
Germany Plans Tobacco Tax Hike, With Cigarette Prices Nearing €12 Per Pack by 2030
Germany Plans Tobacco Tax Hike, With Cigarette Prices Nearing €12 Per Pack by 2030
Germany plans to raise tobacco taxes over the coming years, potentially pushing the average price of a 20-cigarette pack to about €11.78 by 2030. The proposal also covers fine-cut tobacco, cigars, pipe tobacco and e-cigarette liquids.
Jul.14
FDA 2025 NYTS: Youth E-Cigarette Use Declines but Unauthorized Disposables Remain Prominent; Nicotine Pouch Use Stays Low
FDA 2025 NYTS: Youth E-Cigarette Use Declines but Unauthorized Disposables Remain Prominent; Nicotine Pouch Use Stays Low
The U.S. Food and Drug Administration (FDA) released its 2025 National Youth Tobacco Survey analysis, saying about 2.01 million U.S. middle and high school students currently used any tobacco product; among current youth e-cigarette users, unauthorized disposable brands including Geek Bar, Elf Bar, Lost Mary and Raz had high reported shares, potentially making them a focus for future enforcement.
Jun.24
Russian Strikes Destroy JTI and Imperial Brands Ukraine Warehouses, With Losses Reaching Tens of Millions of Hryvnias
Russian Strikes Destroy JTI and Imperial Brands Ukraine Warehouses, With Losses Reaching Tens of Millions of Hryvnias
According to Ukrainska Pravda, Russian strikes on the Kyiv region during the night of Aug. 4-5, 2026, damaged warehouses storing products of Japan Tobacco International (JTI) and Imperial Brands Ukraine. JTI said a finished goods warehouse in Kyiv Oblast was destroyed, with no employees injured, and that it did not expect disruptions to retail supplies. Imperial Brands Ukraine said products stored at warehouses of distributors and retail partners were affected and estimated losses from the strikes at “tens of millions of Ukrainian hryvnias” (roughly hundreds of thousands of U.S. dollars).
JTI
Aug.07
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18